Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I3Q1
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0032259 | methylation | 2 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0043414 | macromolecule methylation | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:0000154 | rRNA modification | 6 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0031167 | rRNA methylation | 5 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0070475 | rRNA base methylation | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 86 | 90 | PF00656 | 0.555 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.531 |
CLV_NRD_NRD_1 | 139 | 141 | PF00675 | 0.739 |
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 179 | 181 | PF00675 | 0.531 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.688 |
CLV_NRD_NRD_1 | 26 | 28 | PF00675 | 0.436 |
CLV_NRD_NRD_1 | 309 | 311 | PF00675 | 0.604 |
CLV_NRD_NRD_1 | 428 | 430 | PF00675 | 0.791 |
CLV_NRD_NRD_1 | 493 | 495 | PF00675 | 0.253 |
CLV_PCSK_FUR_1 | 136 | 140 | PF00082 | 0.718 |
CLV_PCSK_FUR_1 | 172 | 176 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.746 |
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.530 |
CLV_PCSK_KEX2_1 | 206 | 208 | PF00082 | 0.717 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.695 |
CLV_PCSK_KEX2_1 | 355 | 357 | PF00082 | 0.254 |
CLV_PCSK_KEX2_1 | 428 | 430 | PF00082 | 0.792 |
CLV_PCSK_PC1ET2_1 | 138 | 140 | PF00082 | 0.722 |
CLV_PCSK_PC1ET2_1 | 181 | 183 | PF00082 | 0.544 |
CLV_PCSK_PC1ET2_1 | 206 | 208 | PF00082 | 0.773 |
CLV_PCSK_PC1ET2_1 | 355 | 357 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 206 | 210 | PF00082 | 0.730 |
CLV_PCSK_SKI1_1 | 284 | 288 | PF00082 | 0.684 |
CLV_PCSK_SKI1_1 | 381 | 385 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 494 | 498 | PF00082 | 0.254 |
CLV_PCSK_SKI1_1 | 527 | 531 | PF00082 | 0.253 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.503 |
CLV_Separin_Metazoa | 524 | 528 | PF03568 | 0.539 |
DEG_APCC_DBOX_1 | 309 | 317 | PF00400 | 0.426 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.408 |
DOC_ANK_TNKS_1 | 138 | 145 | PF00023 | 0.727 |
DOC_CYCLIN_RxL_1 | 19 | 29 | PF00134 | 0.387 |
DOC_CYCLIN_RxL_1 | 488 | 500 | PF00134 | 0.496 |
DOC_MAPK_gen_1 | 155 | 164 | PF00069 | 0.373 |
DOC_MAPK_MEF2A_6 | 158 | 166 | PF00069 | 0.406 |
DOC_PP2B_LxvP_1 | 151 | 154 | PF13499 | 0.488 |
DOC_PP2B_LxvP_1 | 333 | 336 | PF13499 | 0.453 |
DOC_PP2B_PxIxI_1 | 335 | 341 | PF00149 | 0.530 |
DOC_USP7_MATH_1 | 193 | 197 | PF00917 | 0.765 |
DOC_USP7_MATH_1 | 246 | 250 | PF00917 | 0.417 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.733 |
DOC_USP7_MATH_1 | 391 | 395 | PF00917 | 0.453 |
DOC_USP7_UBL2_3 | 28 | 32 | PF12436 | 0.435 |
DOC_USP7_UBL2_3 | 284 | 288 | PF12436 | 0.774 |
LIG_14-3-3_CanoR_1 | 158 | 163 | PF00244 | 0.373 |
LIG_14-3-3_CanoR_1 | 210 | 215 | PF00244 | 0.727 |
LIG_14-3-3_CanoR_1 | 257 | 265 | PF00244 | 0.363 |
LIG_14-3-3_CanoR_1 | 356 | 361 | PF00244 | 0.465 |
LIG_14-3-3_CanoR_1 | 381 | 389 | PF00244 | 0.539 |
LIG_14-3-3_CanoR_1 | 428 | 434 | PF00244 | 0.662 |
LIG_14-3-3_CanoR_1 | 93 | 102 | PF00244 | 0.511 |
LIG_Actin_WH2_2 | 159 | 176 | PF00022 | 0.436 |
LIG_BIR_III_2 | 268 | 272 | PF00653 | 0.536 |
LIG_BRCT_BRCA1_1 | 369 | 373 | PF00533 | 0.475 |
LIG_Clathr_ClatBox_1 | 501 | 505 | PF01394 | 0.464 |
LIG_FHA_1 | 159 | 165 | PF00498 | 0.403 |
LIG_FHA_1 | 325 | 331 | PF00498 | 0.453 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.383 |
LIG_FHA_1 | 382 | 388 | PF00498 | 0.475 |
LIG_FHA_1 | 512 | 518 | PF00498 | 0.462 |
LIG_FHA_2 | 341 | 347 | PF00498 | 0.533 |
LIG_FHA_2 | 398 | 404 | PF00498 | 0.454 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.473 |
LIG_IRF3_LxIS_1 | 159 | 165 | PF10401 | 0.496 |
LIG_LIR_Gen_1 | 36 | 44 | PF02991 | 0.370 |
LIG_LIR_Gen_1 | 364 | 373 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 104 | 109 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 36 | 40 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 364 | 368 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 370 | 376 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.367 |
LIG_REV1ctd_RIR_1 | 57 | 63 | PF16727 | 0.422 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.355 |
LIG_SH2_CRK | 37 | 41 | PF00017 | 0.383 |
LIG_SH2_CRK | 76 | 80 | PF00017 | 0.374 |
LIG_SH2_GRB2like | 365 | 368 | PF00017 | 0.464 |
LIG_SH2_NCK_1 | 156 | 160 | PF00017 | 0.355 |
LIG_SH2_PTP2 | 365 | 368 | PF00017 | 0.478 |
LIG_SH2_SRC | 365 | 368 | PF00017 | 0.478 |
LIG_SH2_STAP1 | 76 | 80 | PF00017 | 0.374 |
LIG_SH2_STAT3 | 62 | 65 | PF00017 | 0.523 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 315 | 318 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 365 | 368 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 581 | 584 | PF00017 | 0.471 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.517 |
LIG_SH3_3 | 213 | 219 | PF00018 | 0.652 |
LIG_SH3_3 | 224 | 230 | PF00018 | 0.421 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.368 |
LIG_SUMO_SIM_par_1 | 270 | 276 | PF11976 | 0.600 |
LIG_SUMO_SIM_par_1 | 51 | 58 | PF11976 | 0.513 |
LIG_TRAF2_1 | 165 | 168 | PF00917 | 0.523 |
LIG_TRAF2_1 | 449 | 452 | PF00917 | 0.756 |
LIG_WRC_WIRS_1 | 501 | 506 | PF05994 | 0.464 |
LIG_WW_3 | 115 | 119 | PF00397 | 0.541 |
MOD_CK1_1 | 500 | 506 | PF00069 | 0.487 |
MOD_CK1_1 | 513 | 519 | PF00069 | 0.404 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.411 |
MOD_CK2_1 | 477 | 483 | PF00069 | 0.343 |
MOD_CK2_1 | 513 | 519 | PF00069 | 0.478 |
MOD_Cter_Amidation | 136 | 139 | PF01082 | 0.718 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.706 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.578 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.633 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.639 |
MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.435 |
MOD_GlcNHglycan | 393 | 396 | PF01048 | 0.271 |
MOD_GlcNHglycan | 466 | 469 | PF01048 | 0.765 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.429 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.656 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.446 |
MOD_GSK3_1 | 183 | 190 | PF00069 | 0.612 |
MOD_GSK3_1 | 206 | 213 | PF00069 | 0.748 |
MOD_GSK3_1 | 286 | 293 | PF00069 | 0.790 |
MOD_GSK3_1 | 389 | 396 | PF00069 | 0.446 |
MOD_GSK3_1 | 506 | 513 | PF00069 | 0.464 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.474 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.411 |
MOD_N-GLC_1 | 17 | 22 | PF02516 | 0.454 |
MOD_N-GLC_1 | 302 | 307 | PF02516 | 0.707 |
MOD_N-GLC_1 | 324 | 329 | PF02516 | 0.253 |
MOD_N-GLC_1 | 87 | 92 | PF02516 | 0.570 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.381 |
MOD_NEK2_1 | 497 | 502 | PF00069 | 0.494 |
MOD_NEK2_1 | 564 | 569 | PF00069 | 0.453 |
MOD_PIKK_1 | 221 | 227 | PF00454 | 0.571 |
MOD_PIKK_1 | 325 | 331 | PF00454 | 0.478 |
MOD_PIKK_1 | 420 | 426 | PF00454 | 0.559 |
MOD_PIKK_1 | 93 | 99 | PF00454 | 0.504 |
MOD_PKA_1 | 138 | 144 | PF00069 | 0.768 |
MOD_PKA_1 | 206 | 212 | PF00069 | 0.768 |
MOD_PKA_1 | 33 | 39 | PF00069 | 0.403 |
MOD_PKA_1 | 428 | 434 | PF00069 | 0.683 |
MOD_PKA_2 | 138 | 144 | PF00069 | 0.724 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.583 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.674 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.753 |
MOD_PKA_2 | 256 | 262 | PF00069 | 0.369 |
MOD_PKA_2 | 428 | 434 | PF00069 | 0.683 |
MOD_PKA_2 | 540 | 546 | PF00069 | 0.558 |
MOD_PKB_1 | 459 | 467 | PF00069 | 0.580 |
MOD_Plk_1 | 477 | 483 | PF00069 | 0.382 |
MOD_Plk_4 | 497 | 503 | PF00069 | 0.506 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.446 |
MOD_SUMO_for_1 | 129 | 132 | PF00179 | 0.563 |
MOD_SUMO_for_1 | 481 | 484 | PF00179 | 0.530 |
TRG_DiLeu_BaEn_4 | 451 | 457 | PF01217 | 0.543 |
TRG_ENDOCYTIC_2 | 106 | 109 | PF00928 | 0.408 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.356 |
TRG_ENDOCYTIC_2 | 365 | 368 | PF00928 | 0.471 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.355 |
TRG_ENDOCYTIC_2 | 76 | 79 | PF00928 | 0.366 |
TRG_ER_diArg_1 | 172 | 175 | PF00400 | 0.451 |
TRG_ER_diArg_1 | 428 | 430 | PF00400 | 0.660 |
TRG_NLS_MonoExtC_3 | 137 | 143 | PF00514 | 0.710 |
TRG_NLS_MonoExtC_3 | 179 | 184 | PF00514 | 0.619 |
TRG_NLS_MonoExtN_4 | 136 | 142 | PF00514 | 0.712 |
TRG_NLS_MonoExtN_4 | 284 | 291 | PF00514 | 0.705 |
TRG_Pf-PMV_PEXEL_1 | 218 | 222 | PF00026 | 0.574 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I291 | Leptomonas seymouri | 71% | 100% |
A0A0S4JC42 | Bodo saltans | 53% | 100% |
A0A1X0NQY2 | Trypanosomatidae | 58% | 100% |
A0A3S7X1L9 | Leishmania donovani | 98% | 100% |
A0A422NZ09 | Trypanosoma rangeli | 57% | 100% |
A4HGM7 | Leishmania braziliensis | 83% | 98% |
D0A8B0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 100% |
E9AZZ3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
O14039 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 25% | 100% |
Q4Q892 | Leishmania major | 91% | 100% |
Q8GYE8 | Arabidopsis thaliana | 28% | 100% |
Q9NAA7 | Caenorhabditis elegans | 23% | 100% |
V5BAN7 | Trypanosoma cruzi | 58% | 100% |